Immix Biopharma, Inc.

US$8.06As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMMXHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR 18.33%
Div yield —
ROE (34.18%)
Biotechnology
Beta (5Y) 0.29
PE TTM —
TSR TTM 112.11%
Mkt cap US$668.2M
ROIC (22.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.23
14.53%
(34.55%)
Sell 1|2|1|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.16
0.17
4.03%
5.26%
12.62%
15.88%
Revenue$M
50.45
52.02
54.02
52.56
7.61%
10.56%
10.76%
10.31%
Peers (US$668.2M)
Cap (US$)
PE
666.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.462
0.106
0.113
EBIT/Intx
0.543
2.169
1.753
Own earn%
6.70
149.73
138.20
Sh yield%
29.44
25.08
25.70
Owners
Insiders/Inst%
14.06
40.54
Short interest%
2.00
SBC / revenue%
3.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–23
$1 testx
0.2
Incr. ROIC%
33